LAXMI SANKALPA BHAGANAGARAPU; SARUMATHY SUNDARARAJAN. NOVEL APPROACHES FOR ANEMIA IN CARDIORENAL SYNDROME: A RANDOMIZED CONTROLLED TRIAL OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR VS SGLT2 INHIBITOR. Asian J Pharm Clin Res 2025, 18, 184-191.